Raymond James & Associates’s Ovid Therapeutics OVID Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-25,000	Closed	-$82K	–	3838
2023 Q2	$82K	Buy	+25,000	New	+$82K	﹤0.01%	3618